CLINICAL_TRIALS
trial_result
· 2026-03-24
Clinical Trial Update: Lemborexant Augmentation of Naltrexone for Alcohol Craving and Sleep [Phase 3]
Summary
A Phase 3 study evaluated adding lemborexant to naltrexone to reduce alcohol craving and improve sleep in adults with alcohol use disorder; results have been po…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baylor College of Medicine | Conditions: Alcohol Use Disorder | Phase 3 | Status: COMPLETED | Results posted: 2026-03-24